FDA Allows Early Release of COVID-19 Diagnostics

By Sam | March 6, 2020

The FDA issued a new policy that will allow certain laboratories to use validated COVID-19 diagnostics while the agency reviews their Emergency Use Authorization (EUA) requests.
Source: The GMP Letter

Posted in The GMP Letter